Mast Cell Activation Syndrome (MCAS) is often underdiagnosed due to its diverse clinical presentation and the need for more awareness among healthcare professionals.
The exact prevalence remains uncertain, but estimates suggest that approximately 1% of the population may have some form of mast cell activation disorder with symptoms.
Mast Cell Activation Syndrome (MCAS) is a complex disorder characterized by the inappropriate activation of mast cells, leading to the release of various mediators such as histamine, prostaglandins, and cytokines. These mediators can cause various symptoms affecting multiple organ systems, including skin, gastrointestinal tract, cardiovascular system, and respiratory system.
While there currently is no cure for MCAS, continued research and promising treatments including antihistamines and mast cell stabilizers help patients regain control of their symptoms and see the light ahead.
RTHM provides prescription access to a variety of medications for Long COVID, ME/CFS, POTS and MCAS
Not sure which treatment might be right for MCAS? Start with RTHM at no cost.
Our free intelligence platform builds a personalized Health Roadmap based on your history, symptoms, and health records—helping highlight which treatments or labs may be most relevant to your case.
@potszebra
"I lost years of my life feeling like I needed a heart transplant. My doctors told me there wasn't a medication that treated POTS and I actually believed them! Until I found RTHM."
"RTHM has been a huge lifeline in a maze of finding out what's happening to my life with Long COVID and effective treatments for such complex, new issues."
"RTHM is peak healthcare and should be used as a blueprint for a new standard of care all over. Thank you for saving me."